Environmentally responsive hydrogels for delivery

Patent metadata

Field	Value
Publication number	US-9498545-B1
Application number	US-201414585449-A
Country	US
Kind code	B1
Filing date	Dec 30, 2014
Priority date	Oct 24, 2014
Publication date	Nov 22, 2016
Grant date	Nov 22, 2016

Abstract

A nanosensor-containing polymer composition for the monitoring of physiological parameters and a method for making the composition are disclosed. The composition includes a fluid nanosensor-containing polymer that becomes rigid in the presence of physiological conditions. In the fluid form, the composition can be suitable for injection on to or into the skin. In the rigid form, the nanosensor is substantially immobilized in the polymer. The method includes forming a mixture comprising a nanosensor and polymer precursor(s), subjecting the mixture to conditions suitable for forming the fluid form of the composition; and subjecting the fluid form to physiological conditions to provide a rigid nanosensor-containing composition.

First claim

What is claimed is:

1. A composition, comprising:
a nanosensor comprising a nanoparticle having a detectable label, wherein the nanosensor is configured to interact with a specific analyte in an intradermal environment; and
a polymer comprising first monomer-derived units and second monomer-derived units, wherein
the first monomer-derived units have the structure of formula (Ia):

wherein
X is —O— or —S—;
y is 0-10;
R 1 is hydrogen or methyl; and
R 2 is hydrogen, —C 1 -C 12 alkyl, —C 1 -C 12 alkyl-OH, —SiR′ 3 , —C(O)—C 1 -C 12 alkyl, —C 1 -C 12 alkyl-C(O)OR′, wherein R′ is —C 1 -C 12 alkyl,

the second monomer-derived units have the structure of formula (II):

wherein
R 3 is a hydrophobic group; and
R 4 is hydrogen or methyl,

wherein the polymer is configured to change from a fluid form to a rigid form in response to a temperature increase;
wherein the nanosensor is disposed in the polymer.

2. The composition of claim 1 , wherein the temperature increase can be achieved by transdermal application into the intradermal environment.

3. The composition of claim 1 , wherein the first monomer-derived units are derived from poly(ethylene glycol) methyl ether methacrylate.

4. The composition of claim 1 , wherein R 3 is —C 1 -C 12 alkyl, cycloalkyl, or aryl.

5. The composition of claim 1 , wherein the second monomer-derived units are derived from N-isopropylacrylamide.

6. The composition of claim 1 , wherein the detectable label comprises a fluorophore.

7. The composition of claim 1 , wherein the ratio of the first monomer-derived units and second monomer-derived units in the copolymer is about 90:10.

8. The composition of claim 1 , wherein the ratio of the first monomer-derived units and second monomer-derived units in the copolymer is about 80:20.

9. The composition of claim 1 , wherein the ratio of the first monomer-derived units and second monomer-derived units in the copolymer is about 70:30.

10. The composition of claim 1 , wherein the ratio of the first monomer-derived units and second monomer-derived units in the copolymer is about 60:40.

11. The composition of claim 1 , wherein the ratio of the first monomer-derived units and second monomer-derived units in the copolymer is about 50:50.

Assignees

• Verily Life Sciences Llc

Inventors

• Kam Kimberly
• Schwartz Jerrod Joseph

Classifications

• C08F220/286

  and containing polyethylene oxide in the alcohol moiety, e.g. methoxy polyethylene glycol (meth)acrylate · CPC title

• A61K49/0054

  Macromolecular compounds, i.e. oligomers, polymers, dendrimers · CPC title

• A61K49/0006 Primary

  Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity · CPC title

• A61K49/0073

  semi-solid, gel, hydrogel, ointment · CPC title

• C08K11/00

  Use of ingredients of unknown constitution, e.g. undefined reaction products · CPC title